Concepedia

Petros Nikolopoulos

PN

9

Publications

572

Citations

9

H-Index

2004

Active since

Affiliations

Bayer (United States)(Current)

University of Alberta

Merck & Co., Inc., Rahway, NJ, USA (United States)

Canadian VIGOUR Centre

University of Colorado Anschutz Medical Campus

Petros Nikolopoulos is an author at Bayer (United States) specializing in urology, nephrology, and hemodialysis.

ORCID

Top concepts

Publications per year

2004–2025

9

Publications

9

Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial

Chariclia Gouva, Petros Nikolopoulos, John P. A. Ioannidis et al. · Kidney International · 2004 · 407 citations · Full text

, , +7

Correction of Anemia with Erythropoietin in Chronic Kidney Disease (stage 3 or 4): Effects on Cardiac Performance

Chariklia Gouva, K. Katopodis, Petros Nikolopoulos et al. · Cardiovascular Drugs and Therapy · 2007 · 37 citations

, , +11

Sevelamer Hydrochloride versus Aluminum Hydroxide: Effect on Serum Phosphorus and Lipids in CAPD Patients

K. Katopodis, Emilios Andrikos, Chariklia Gouva et al. · Peritoneal Dialysis International · 2006 · 32 citations

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 29 citations · Full text

A randomized trial of a nurse-led educational intervention in patients with heart failure and their caregivers: impact on caregiver outcomes

Maria Thodi, Vasiliki Bistola, Ekaterini Lambrinou et al. · European Journal of Cardiovascular Nursing · 2022 · 18 citations · Full text

Rows per page

1–5 of 9